GENEVA, Nov 21: The World Health Organization said on Friday it has suspended Gilead’s remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised COVID-19 patients.
LONDON, Nov 20: Gilead’s remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday.
KATHMANDU, Nov 8: Remdesivir, an antiviral medication, which has been permitted to be used as an emergency medication against COVID-19 by the government, has been found being sold at exorbitantly higher prices.
SARS-CoV-2 has emerged as a worldwide public health crisis and embattled not only the countries that are at the frontiers of medicine and research, but also developing countries like Nepal. With no effective vaccine against the virus developed to date, experts expect the toll of the COVID-19 pandemic to persist. The grim forecast is deeply concerning for Nepal, where the COVID-19 cases continue to surge, and the state remains unequipped to treat the afflicted patients and reduce community transmission.